Week In Review: 4 China Biopharmas Announce $100+ Million Deals In First Week Of 2020

Nanjing's ASK Pharm (Beijing Aosaikang Pharmaceutical) announced a $51 million agreement for greater China rights to a treatment for iron deficiency from Shield Therapeutics of the UK. Shanghai's Zai ...

Read the original article: shanghai china - BingNews